Leonard Frank X's Form 4 filing
NovoCure Ltd (NVCR) · filed Sep 19, 2022
- Accession no.
- 0001645113-22-000082
- Filed
- Sep 19, 2022
- Trade date
- Sep 15, 2022
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 3 non-derivative transactions and 1 derivative transaction. Open-market sales total $1.09M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Leonard Frank XCIK 0001822879 | Officer (Chief Development Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 15, 2022 | Ordinary Shares | MOption exerciseAcquired | +5,517 | $7.15 | +$39,446.55 | 82,913 | Direct | |
| Sep 15, 2022 | Ordinary Shares | SSaleDisposed | −6,754 | $87.31 | −$589,691.74 | 76,159 | Direct | |
| Sep 15, 2022 | Ordinary Shares | SSaleDisposed | −5,517 | $90.00 | −$496,530 | 70,642 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 15, 2022 | Ordinary Shares | MOption exerciseDisposed | −5,517 | $0.00 | $0 | 5,517 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.